Literature DB >> 22890804

Voxel-based analysis of whole-brain effects of age and gender on dopamine transporter SPECT imaging in healthy subjects.

Alexandre Eusebio1, Jean-Philippe Azulay, Mathieu Ceccaldi, Nadine Girard, Olivier Mundler, Eric Guedj.   

Abstract

PURPOSE: Several studies have shown age- and gender-related differences in striatal dopamine transporter (DaT) binding. These studies were based on a striatal region on interest approach that may have underestimated these effects and could not evaluate extrastriatal regions. Our aim was to determine the effects at the voxel level of age and gender on whole-brain DaT distribution using [(123)I]FP-CIT SPECT in healthy subjects.
METHODS: We performed a whole-brain [(123)I]FP-CIT SPECT voxel-based analysis using SPM8 and a standardized normalization template (p < 0.05, corrected using the false discovery rate method) in 51 healthy subjects aged from 21 to 79 years.
RESULTS: We found an age-related DaT binding decrease in the striatum, anterior cingulate/medial frontal cortices and insulo-opercular cortices. Also DaT binding ratios were higher in women than men in the striatum and opercular cortices.
CONCLUSION: This study showed both striatal and extrastriatal age-related and gender-related differences in DaT binding in healthy subjects using a whole-brain voxel-based non-a priori approach. These differences highlight the need for careful age and gender matching in DaT analyses of neuropsychiatric disorders.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22890804     DOI: 10.1007/s00259-012-2207-8

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN: 1619-7070            Impact factor:   9.236


  22 in total

1.  Association between age-related decline in brain dopamine activity and impairment in frontal and cingulate metabolism.

Authors:  N D Volkow; J Logan; J S Fowler; G J Wang; R C Gur; C Wong; C Felder; S J Gatley; Y S Ding; R Hitzemann; N Pappas
Journal:  Am J Psychiatry       Date:  2000-01       Impact factor: 18.112

Review 2.  Ageing and the nigrostriatal dopaminergic system.

Authors:  S Reeves; C Bench; R Howard
Journal:  Int J Geriatr Psychiatry       Date:  2002-04       Impact factor: 3.485

3.  Dopamine transporters decrease with age.

Authors:  N D Volkow; Y S Ding; J S Fowler; G J Wang; J Logan; S J Gatley; R Hitzemann; G Smith; S D Fields; R Gur
Journal:  J Nucl Med       Date:  1996-04       Impact factor: 10.057

4.  Striatal dopamine transporter availability with [123I]beta-CIT SPECT is unrelated to gender or menstrual cycle.

Authors:  Susan E Best; Philip M Sarrel; Robert T Malison; Marc Laruelle; Sami S Zoghbi; Ronald M Baldwin; John P Seibyl; Robert B Innis; Christopher H van Dyck
Journal:  Psychopharmacology (Berl)       Date:  2005-11-09       Impact factor: 4.530

5.  Effects of age on dopamine and serotonin receptors measured by positron tomography in the living human brain.

Authors:  D F Wong; H N Wagner; R F Dannals; J M Links; J J Frost; H T Ravert; A A Wilson; A E Rosenbaum; A Gjedde; K H Douglass
Journal:  Science       Date:  1984-12-21       Impact factor: 47.728

6.  The role of the striatal dopamine transporter in cognitive aging.

Authors:  Nina Erixon-Lindroth; Lars Farde; Tarja-Brita Robins Wahlin; Judit Sovago; Christer Halldin; Lars Bäckman
Journal:  Psychiatry Res       Date:  2005-01-30       Impact factor: 3.222

7.  Validation of a standardized normalization template for statistical parametric mapping analysis of 123I-FP-CIT images.

Authors:  Aurélie Kas; Pierre Payoux; Marie-Odile Habert; Zoulikha Malek; Yann Cointepas; Georges El Fakhri; Philippe Chaumet-Riffaud; Emmanuel Itti; Philippe Remy
Journal:  J Nucl Med       Date:  2007-08-17       Impact factor: 10.057

8.  Regional analysis of age-related decline in dopamine transporters and dopamine D2-like receptors in human striatum.

Authors:  Kenji Ishibashi; Kenji Ishii; Keiichi Oda; Keiichi Kawasaki; Hidehiro Mizusawa; Kiichi Ishiwata
Journal:  Synapse       Date:  2009-04       Impact factor: 2.562

9.  Age-related decline in striatal dopamine transporter binding with iodine-123-beta-CITSPECT.

Authors:  C H van Dyck; J P Seibyl; R T Malison; M Laruelle; E Wallace; S S Zoghbi; Y Zea-Ponce; R M Baldwin; D S Charney; P B Hoffer
Journal:  J Nucl Med       Date:  1995-07       Impact factor: 10.057

10.  Comparison of two pet radioligands for imaging extrastriatal dopamine transporters in human brain.

Authors:  G J Wang; N D Volkow; J S Fowler; Y S Ding; J Logan; S J Gatley; R R MacGregor; A P Wolf
Journal:  Life Sci       Date:  1995       Impact factor: 5.037

View more
  19 in total

1.  Comments on Eusebio et al.: Voxel-based analysis of whole-brain effects of age and gender on dopamine transporter SPECT imaging in healthy subjects.

Authors:  Jan Booij; Elsmarieke van de Giessen; Swen Hesse; Osama Sabri
Journal:  Eur J Nucl Med Mol Imaging       Date:  2012-10-24       Impact factor: 9.236

2.  Voxel-based analysis of age and gender effects on striatal [123I] FP-CIT binding in healthy Japanese adults.

Authors:  Yoko Shigemoto; Hiroshi Matsuda; Yukio Kimura; Emiko Chiba; Masahiro Ohnishi; Moto Nakaya; Norihide Maikusa; Masayo Ogawa; Yohei Mukai; Yuji Takahashi; Kazuya Sako; Hiroshi Toyama; Yoshitaka Inui; Yasuyuki Taki; Hiroshi Nagayama; Kenjiro Ono; Atsushi Kono; Kenji Sekiguchi; Shigeki Hirano; Noriko Sato
Journal:  Ann Nucl Med       Date:  2022-02-16       Impact factor: 2.258

3.  Physiological Whole-Brain Distribution of [18F]FDOPA Uptake Index in Relation to Age and Gender: Results from a Voxel-Based Semi-quantitative Analysis.

Authors:  Sinn-Rithy Toch; Sylvain Poussier; Emilien Micard; Marc Bertaux; Axel Van Der Gucht; Elodie Chevalier; Pierre-Yves Marie; Eric Guedj; Antoine Verger
Journal:  Mol Imaging Biol       Date:  2019-06       Impact factor: 3.488

4.  From metabolic connectivity to molecular connectivity: application to dopaminergic pathways.

Authors:  Antoine Verger; Tatiana Horowitz; Mohammad B Chawki; Alexandre Eusebio; Manon Bordonne; Jean-Philippe Azulay; Nadine Girard; Eric Guedj
Journal:  Eur J Nucl Med Mol Imaging       Date:  2019-11-18       Impact factor: 9.236

5.  Effect of sex on aging-related decline of dopamine transporter in healthy subjects.

Authors:  Seunghyeon Shin; Hyun-Yeol Nam; Myung Jun Lee; Kyoungjune Pak; Keunyoung Kim; In Joo Kim
Journal:  Ann Nucl Med       Date:  2020-10-14       Impact factor: 2.668

6.  Prenatal stress induces increased striatal dopamine transporter binding in adult nonhuman primates.

Authors:  Alexander K Converse; Colleen F Moore; Jeffrey M Moirano; Elizabeth O Ahlers; Julie A Larson; Jonathan W Engle; Todd E Barnhart; Dhanabalan Murali; Bradley T Christian; Onofre T DeJesus; James E Holden; Robert J Nickles; Mary L Schneider
Journal:  Biol Psychiatry       Date:  2013-05-29       Impact factor: 13.382

7.  Establishing On-Site Reference Values for (123)I-FP-CIT SPECT (DaTSCAN®) Using a Cohort of Individuals with Non-Degenerative Conditions.

Authors:  Nicolas Nicastro; Valentina Garibotto; Antoine Poncet; Simon Badoud; Pierre R Burkhard
Journal:  Mol Imaging Biol       Date:  2016-04       Impact factor: 3.488

8.  Impact of age and sex correction on the diagnostic performance of dopamine transporter SPECT.

Authors:  Helen Schmitz-Steinkrüger; Catharina Lange; Ivayla Apostolova; Franziska L Mathies; Lars Frings; Susanne Klutmann; Sabine Hellwig; Philipp T Meyer; Ralph Buchert
Journal:  Eur J Nucl Med Mol Imaging       Date:  2020-10-31       Impact factor: 9.236

9.  Single-site 123I-FP-CIT reference values from individuals with non-degenerative parkinsonism-comparison with values from healthy volunteers.

Authors:  Rachid Fahmi; Günther Platsch; Alexandre Bani Sadr; Sylvain Gouttard; Stephane Thobois; Sven Zuehlsdorff; Christian Scheiber
Journal:  Eur J Hybrid Imaging       Date:  2020-03-13

10.  Source-Based Morphometry Multivariate Approach to Analyze [123I]FP-CIT SPECT Imaging.

Authors:  Enrico Premi; V D Calhoun; V Garibotto; R Turrone; A Alberici; E Cottini; A Pilotto; S Gazzina; M Magoni; B Paghera; B Borroni; A Padovani
Journal:  Mol Imaging Biol       Date:  2017-10       Impact factor: 3.488

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.